Skip to main content
Back
Watch Compare

Annovis Bio, Inc.

Data quality: 100%
ANVS
NYSE Manufacturing Chemicals
$1.59
▼ $0.03 (-1.85%)
Mkt Cap: 46.29 M
Price
$1.63
Mkt Cap
46.29 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -25.62 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-183.28%
Below sector avg (-53.34%)
ROIC-146.14%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Valuation

PE (TTM)
-1.60
Below sector avg (-1.47)
P/B Ratio3.52
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.6 -1.5
P/B 3.5 1.6
ROE % -183.3 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

2 analysts
Strong Buy
Current
$1.59
+686.2%
Target
$12.50
$8.00
$12.50
$17.00
Forecast
Forward P/E -1.47
Forward EPS -$1.08
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$1.08
-$1.08 – -$1.08
 0.0 1
FY2026 -$1.10
-$1.10 – -$1.10
 0.0 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.30 -$0.39 -30.0%
Q32025 -$0.37 -$0.37 0.0%
Q22025 -$0.39 -$0.32 +18.0%
Q12025 -$0.29 -$0.32 -10.3%

ETFs Holding This Stock

BRSIX BRSIX
0.02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -28.85 M
ROE -183.28% ROA -149.34%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -25.62 M
ROIC -146.14% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover 0.00
Working Capital N/A Tangible Book Value 13.16 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.60 Forward P/E N/A
P/B Ratio 3.52 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -55.34%
Market Cap 46.29 M Enterprise Value 31.01 M
Per Share
EPS (Diluted TTM) -1.40 Revenue / Share 0.00
FCF / Share -0.90 OCF / Share -0.90
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 88.79%
SBC-Adj. FCF -27.45 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -28.85 M -24.59 M -56.20 M -25.33 M -14.49 M
EPS (Diluted) -1.40 -2.31 -6.23 -3.10 -1.90
Gross Profit — — — — —
Operating Income -29.70 M -26.69 M -45.04 M -25.51 M -14.54 M
EBITDA — — — — —
R&D Expenses 25.22 M 20.00 M 38.79 M 16.52 M 8.48 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 21.08 M 13.93 M 10.21 M 36.02 M 46.00 M
Total Liabilities 4.23 M 4.62 M 17.96 M 7.70 M 1.51 M
Shareholders' Equity 16.85 M 9.31 M -7.75 M 28.32 M 44.49 M
Total Debt — — — — —
Cash & Equivalents 19.53 M 10.55 M 5.75 M 28.38 M 45.69 M
Current Assets — — 10.21 M 36.02 M 46.00 M
Current Liabilities 3.64 M 3.88 M 4.28 M 7.70 M 1.51 M